A clinical trial testing the oral therapy tebapivat for sickle cell disease is fully enrolled, with early results expected later this year.
Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...
Members of Fulcrum management will be joined by Dr. Martin Steinberg, Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine at Boston University Chobanian and Avedisian School of ...
September 18, 2024 (Houston Style Magazine) — In a historic move aimed at spotlighting a vital public health issue, the U.S. Department of Health and Human Services (HHS) will hold its first-ever ...
This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from the American Society of Hematology. The articles in the series are ...
This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from The American Society of Hematology. The articles in the series are ...
The Ministry of Health has reiterated its commitment to combating sickle cell disease (SCD) in Ghana, describing it as a significant public health challenge that requires sustained national action and ...
The second floor of the Indiana Statehouse was filled with "Warriors" on Monday as more than 1,700 Hoosiers living with ...
Newborn screening will now be mandatory at birth, and children diagnosed with the disease will be followed up to manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results